140 related articles for article (PubMed ID: 38551114)
1. Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells.
Consuegra-Asprilla JM; Rodríguez-Echeverri C; Posada DH; Gómez BL; González Á
Mycoses; 2024 Apr; 67(4):e13720. PubMed ID: 38551114
[TBL] [Abstract][Full Text] [Related]
2. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
[TBL] [Abstract][Full Text] [Related]
5. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Diagn Microbiol Infect Dis; 2024 May; 109(1):116242. PubMed ID: 38452558
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
8. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
[TBL] [Abstract][Full Text] [Related]
9. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
Front Immunol; 2022; 13():959740. PubMed ID: 35967437
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women.
Gunther LS; Martins HP; Gimenes F; Abreu AL; Consolaro ME; Svidzinski TI
Sao Paulo Med J; 2014; 132(2):116-20. PubMed ID: 24714993
[TBL] [Abstract][Full Text] [Related]
11. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
[TBL] [Abstract][Full Text] [Related]
14. Microbicidal activity of neutrophils is inhibited by isolates from recurrent vaginal candidiasis (RVVC) caused by Candida albicans through fungal thioredoxin reductase.
Ratti BA; Godoy JS; de Souza Bonfim Mendonça P; Bidóia DL; Nakamura TU; Nakamura CV; Lopes Consolaro ME; Estivalet Svidzinski TI; de Oliveira Silva S
Cell Immunol; 2015 Jan; 293(1):22-9. PubMed ID: 25497972
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
16. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil.
Boatto HF; Cavalcanti SD; Del Negro GM; Girão MJ; Francisco EC; Ishida K; Gompertz OF
Mem Inst Oswaldo Cruz; 2016 Jun; 111(6):407-10. PubMed ID: 27304096
[TBL] [Abstract][Full Text] [Related]
17. Recurrent vulvovaginal candidiasis.
Sobel JD
Am J Obstet Gynecol; 2016 Jan; 214(1):15-21. PubMed ID: 26164695
[TBL] [Abstract][Full Text] [Related]
18. Propolis increases neutrophils response against Candida albicans through the increase of reactive oxygen species.
Alves de Lima NC; Ratti BA; Souza Bonfim Mendonça P; Murata G; Araujo Pereira RR; Nakamura CV; Lopes Consolaro ME; Estivalet Svidzinski TI; Hatanaka E; Bruschi ML; Oliveira Silva S
Future Microbiol; 2018 Feb; 13():221-230. PubMed ID: 29302986
[TBL] [Abstract][Full Text] [Related]
19. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
Shao MK; Qi WJ; Hou MY; Luo DD
J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
[TBL] [Abstract][Full Text] [Related]
20. Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy.
Phillips NA; Rocktashel M; Merjanian L
Drug Des Devel Ther; 2023; 17():363-367. PubMed ID: 36785761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]